Rystiggo needs marketing strategy to fully compete in myasthenia gravis space, says GlobalData
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
Decisions on the marketing authorization for Rystiggo in the European and Japanese markets are expected in Q1 of 2024
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
Effective disaster response and management is a collaborative work
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Columvi is part of Roche's industry-leading portfolio of T-cell engaging bispecific antibodies in non-Hodgkin lymphoma, which also includes the recently approved Lunsumio to treat follicular lymphoma
Convergent action on AMR identified as an important area of intervention
Urges Innovators to produce quality products that can be deployed at scale
The slogan for this year's World Blood Donor Day campaign is 'Give blood, give plasma, share life, share often'
Subscribe To Our Newsletter & Stay Updated